XTalks

APRIL 29, 2021

Proviral DNA Genotyping. In the HIV space, proviral DNA resistance testing is the newest genotypic resistance testing to be incorporated into the day-to-day management of patients living with HIV, explains Dr. Walworth. Importantly, ARV treatment does not affect the proviral DNA genome that persists in latently infected cells.

DNA 98

DNA Drugs RNA Genotype 98

XTalks

FEBRUARY 4, 2021

Through these collaborations, cohort research dataset sharing programs allow for whole-genome sequence and genotype data to be made available for independent research. Dr. Samantha Hutten, staff scientist at the Michael J. Genotype Data Curation and Return of Results. Sample Collection Standardization.

Research 98

Research Biobanking Drugs Genome 98

XTalks

NOVEMBER 10, 2020

We’re also seeing longer times for the interpretation of the test data, since even experienced scientists cannot be an expert on every gene they encounter. We also offer interpretation and reporting services delivered by our in-house team of clinical scientists working in the UK.

Genome 98

Genome Genomics Medicine Genetic Disease 98

XTalks

DECEMBER 12, 2023

Director of Scientific Affairs at Medpace Core Labs; and Serena Allen, PhD, Principal Scientist at Medpace Central Labs. To accurately identify these genetic factors, genotyping techniques such as Sanger sequencing, next-generation sequencing (NGS) and copy number variant analysis are used. Holland, PhD, Sr.

Trials 111

Trials Clinical Trials Clinical Trials Genetics 111

Roots Analysis

AUGUST 31, 2023

Current Approaches / Processes for Offering Genomic Tests Presently, owing to the significant reduction in the cost of genotyping and sequencing, there has been a significant rise in the number of nutrigenomics companies offering genetic testing services directly to the consumers without the involvement of clinicians.

Genome 40

Genome Genomics Genetics Gene 40

pharmaphorum

JANUARY 18, 2023

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. Giving participants something in return.

Genetic Disease 97

Genetic Disease Genetics Research Genome 97

XTalks

MARCH 3, 2021

In the analysis involving 31 patients, 13 were treated with Nulibry and compared to 18 genotype-matched untreated patients from the history control group. The efficacy of Nulibry in the treatment of MoCD Type A was demonstrated in data from three different clinical trials that was compared to data from a natural history study.

FDA Approval 64

FDA Approval Genotype Clinical Trials Clinical Trials 64